Study of prevalence of thyroid peroxidase antibodies in preterm deliveries and recurrent pregnancy loss
DOI:
https://doi.org/10.18203/2320-1770.ijrcog20222810Keywords:
Preterm, Recurrent pregnancy loss, Thyroid peroxidase antibodiesAbstract
Background: Evaluation of thyroid disorder in pregnancy is essential for maternal health, obstetrical outcome and neurodevelopment of the child. Euthyroid pregnant women having positive thyroid peroxidase antibodies have an elevated risk of miscarriage, premature birth, gestational hypertension, and intrauterine fetal demise. Thyroid autoimmunity (TAI) and subclinical hypothyroidism (SCH) have been connected with adverse outcomes in pregnancy and foetus. The present aim of the study was to estimate the prevalence of TPO antibodies in recurrent pregnancy losses, first trimester abortions and preterm deliveries.
Methods: This was a hospital-based cross-sectional prevalence study conducted for 18 months. The study consists of 100 women who had preterm deliveries and miscarriages attending to department of obstetrics and gynaecology, Narayana medical college and hospital, Nellore, Andhra Pradesh.
Results: In our study out of 100 cases, 11 had high thyroid peroxidase antibody (TPOAb) levels, of which 9 had preterm deliveries and 2 had miscarriages. Out of 100 cases 5 cases had elevated T3 levels, 6 cases had elevated T4 levels and 24 cases had elevated TSH levels.
Conclusions: There was a statistically significant association of thyroid peroxidase antibodies (TPOAb) with T3, T4, and, TSH (P<0.05) and it leads to developing hypothyroidism during pregnancy. The presence of TPOAb in pregnant women significantly increases the risk of preterm delivery. The screening of TSH and thyroid peroxidase antibodies is essential during pregnancy to avoid complications. So, screening T3, T4, TSH and thyroid peroxidase antibodies are essential during pregnancy to avoid complications.
References
Gahlawat P, Singh A, Nanda S, Kharb S. Thyroid dysfunction in early pregnancy and spontaneous abortion. Biomed Biotechnol Res J. 2017;1(1):81.
Mahdi ZS, Selman MO, Mohammad SM, Suhail AM. The impact of positive thyroid peroxidase antibody in patients with unexplained recurrent miscarriage. Res J Pharm Technol. 2020;13(10):4702-6.
Suryanarayana MS, Vellingiri K, Mohan B. Can early thyroid profiling help avert spontaneous abortions/early pregnancy loss: a retrospective study. Cureus. 2021;13(9).
Negro R, Schwartz A, Gismondi R, Tinelli A, Mangieri T, Stagnaro-Green A. Thyroid antibody positivity in the first trimester of pregnancy is associated with negative pregnancy outcomes. J Clin Endocrinol Metab. 2011;96(6):E920-4.
Castillo Lara M, Vilar Sánchez Á, Cañavate Solano C, Soto Pazos E, Iglesias Álvarez M, González Macías C, et al. Hypothyroidism screening during first trimester of pregnancy. BMC Pregnancy Childbirth. 2017;17(1):1-7.
Yuan N, Sun J, Li Z, Chai S, Zhang X, Ji L. Relationship between anti-thyroid peroxidase antibody positivity and pregnancy-related and fetal outcomes in Euthyroid women: a single-center cohort study. BMC Pregnancy Childbirth. 2020;20(1):1-10.
Stagnaro-Green A, Glinoer D. Thyroid autoimmunity and the risk of miscarriage. Best Pract Res Clin Endocrinol Metab. 2004;18(2):167-81.
Negro R, Formoso G, Coppola L, Presicce G, Mangieri T, Pezzarossa A, et al. Euthyroid women with autoimmune disease undergoing assisted reproduction technologies: the role of autoimmunity and thyroid function. J Endocrinol Investig. 2007;30(1):3-8.
Lata K, Dutta P, Sridhar S, Rohilla M, Srinivasan A, Prashad GRV, et al. Thyroid autoimmunity and obstetric outcomes in women with recurrent miscarriage: a case– control study. Endocr Connect. 2013;2(2):118-24.
Bhattacharyya R, Mukherjee K, Das A, Biswas MR, Basunia SR, Mukherjee A. Anti- thyroid peroxidase antibody positivity during early pregnancy is associated with pregnancy complications and maternal morbidity in later life. J Nat Sci Biol Med. 2015;6(2):402-5.
Meena M, Chopra S, Jain V, Aggarwal N. The effect of anti-thyroid peroxidase antibodies on pregnancy outcomes in euthyroid women. J Clin Diagn Res. 2016;10(9):QC04-7.
Meena A, Nagar P. Pregnancy outcome in euthyroid women with anti-thyroid peroxidase antibodies. J Obstet Gynecol India. 2016;66(3):160-5.
Pluchino N, Drakopoulos P, Wenger JM, Petignat P, Streuli I, Genazzani AR. Hormonal causes of recurrent pregnancy loss (RPL). Hormones. 2014;13(3):314-22.
